991 related articles for article (PubMed ID: 35251600)
21. Drug-aggravated Bullous Pemphigoid in a 47-year-old Asian Woman - A Case Report.
Nelramachandrakumar D; Hariharan H; Nagamanickam S; Chander J SJU
Curr Drug Saf; 2023; 18(3):379-382. PubMed ID: 35593331
[TBL] [Abstract][Full Text] [Related]
22. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
McMahon DE; Kovarik CL; Damsky W; Rosenbach M; Lipoff JB; Tyagi A; Chamberlin G; Fathy R; Nazarian RM; Desai SR; Lim HW; Thiers BH; Hruza GJ; French LE; Blumenthal K; Fox LP; Freeman EE
J Am Acad Dermatol; 2022 Jan; 86(1):113-121. PubMed ID: 34517079
[TBL] [Abstract][Full Text] [Related]
24. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
25. Analyzing COVID-19 Vaccination Side Effects Among the Adult Population in Jeddah, Saudi Arabia.
Alamri T; Anwer F; Butt NS; Alganmi AH; Alotaibi SA; Alzibali KF; Hawsawi HA; Bakarman M; Malik AA
Cureus; 2023 Oct; 15(10):e47136. PubMed ID: 37854474
[TBL] [Abstract][Full Text] [Related]
26. Bullous Pemphigoid Developed after the COVID-19 Vaccine.
Linares-Navarro R; Ramírez GR; Perandones-González H; Rodríguez-Prieto MÁ
Skinmed; 2023; 21(3):200-202. PubMed ID: 37634107
[TBL] [Abstract][Full Text] [Related]
27. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
28. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
[TBL] [Abstract][Full Text] [Related]
29. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
[TBL] [Abstract][Full Text] [Related]
30. Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.
Maronese CA; Caproni M; Moltrasio C; Genovese G; Vezzoli P; Sena P; Previtali G; Cozzani E; Gasparini G; Parodi A; Atzori L; Antiga E; Maglie R; Moro F; Mariotti EB; Corrà A; Pallotta S; Didona B; Marzano AV; Di Zenzo G
Front Med (Lausanne); 2022; 9():841506. PubMed ID: 35295599
[TBL] [Abstract][Full Text] [Related]
31. Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID-19 messenger RNA vaccination.
Choi S; Kim SH; Hwang JH; Jang HW; Oh SH; Kim DY; Kim TG
J Dermatol; 2023 Sep; 50(9):1190-1193. PubMed ID: 37102209
[TBL] [Abstract][Full Text] [Related]
32. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
33. Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.
Alhashim A; Hadhiah K; Al Khalifah Z; Alhaddad FM; Al ARhain SA; Bin Saif FH; Abid A; Al Gamdi O; Alsulaiman F; AlQarni M
Am J Case Rep; 2022 Feb; 23():e934744. PubMed ID: 35136010
[TBL] [Abstract][Full Text] [Related]
34. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study.
Aldali J; Meo SA; Al-Khlaiwi T
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109
[TBL] [Abstract][Full Text] [Related]
35. Urticarial Lesions in a Pregnant Woman.
Santos-Alarcón S; Benavente-Villegas C; García-Briz I; Moneva-Léniz M; Sanchis-Sánchez C; Mateu-Puchades A
Acta Dermatovenerol Croat; 2018 Apr; 26(1):71-72. PubMed ID: 29782306
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
[TBL] [Abstract][Full Text] [Related]
37. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review.
Dighriri IM; Alhusayni KM; Mobarki AY; Aljerary IS; Alqurashi KA; Aljuaid FA; Alamri KA; Mutwalli AA; Maashi NA; Aljohani AM; Alqarni AM; Alfaqih AE; Moazam SM; Almutairi MN; Almutairi AN
Cureus; 2022 Mar; 14(3):e23526. PubMed ID: 35494952
[TBL] [Abstract][Full Text] [Related]
38. Erythema multiforme reactions following Pfizer/BioNTech (tozinameran) vaccination: two case-reports with positive rechallenge and review of the literature.
Charfi O; Lakhoua G; Berrim K; Kastalli S; Aouinti I; Badri T; Daghfous R; Zaiem A; El Aidli S
Curr Drug Saf; 2023 Jul; ():. PubMed ID: 37489779
[TBL] [Abstract][Full Text] [Related]
39. Overt Hypothyroidism Status Post Pfizer-BioNTech Vaccination: A Case Study.
Nandennagari S; Annam P; Naidu N; Vegesna P; Bethala K
Cureus; 2023 Jun; 15(6):e41180. PubMed ID: 37525806
[TBL] [Abstract][Full Text] [Related]
40. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews.
Abu-Halaweh S; Alqassieh R; Suleiman A; Al-Sabbagh MQ; AbuHalaweh M; AlKhader D; Abu-Nejem R; Nabulsi R; Al-Tamimi M; Alwreikat M; Alnouti M; Suleiman B; Yousef M; Jarbeh ME; Al-Shudifat AE; Alqassieh A; Bsisu I
Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
